PhotoPharmics
Latest round
- Series B
Last raised
- Apr 2025
Total raised
- $22M
Investors
- 1
About PhotoPharmics
PhotoPharmics Inc.PhotoPharmics, founded in 2011 in Lehi, US, focuses on creating therapeutic solutions for individuals with neurodegenerative diseases.PhotoPharmics specializes in innovative health solutions aimed at improving the quality of life for individuals with neurodegenerative diseases, particularly Parkinson's disease (PD). The company's flagship product, Celeste® specialized phototherapy, is a non-invasive at-home device designed to address both motor and non-motor symptoms associated with PD. Through personalized light therapy, the device aims to alleviate issues such as sleep disorders, fatigue, and mood disturbances, which are common in PD patients. The company is currently conducting clinical trials, including the “Light-for-PD” trial, to substantiate the safety and efficacy of its therapeutic offerings.PhotoPharmics generates revenue through the commercialization of its specialized phototherapy products, which are positioned for prescription use by healthcare professionals. The company’s business model includes direct-to-consumer sales facilitated through partnerships with medical providers, allowing patients to access the Celeste® device as part of their treatment regimen. Revenue streams are expected to be bolstered by ongoing clinical trials that enhance product visibility and credibility within the healthcare community. Specific pricing information and transaction structures are tailored to accommodate healthcare providers and patients alike, ensuring accessibility and adherence to treatment protocols.In April 2025, PhotoPharmics, Inc.
Who invested in PhotoPharmics
1 investor across 2 rounds
See all investors in PhotoPharmics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about PhotoPharmics
Who invested in PhotoPharmics?
PhotoPharmics has 1 investor on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has PhotoPharmics raised?
PhotoPharmics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did PhotoPharmics last raise money?
PhotoPharmics's most recent round on record is a Series B, in Apr 2025.
What does PhotoPharmics do?
PhotoPharmics is a medical devices & equipment company.
Where is PhotoPharmics headquartered?
PhotoPharmics is headquartered in Lehi, US.
Which VCs invest in companies like PhotoPharmics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at PhotoPharmics's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like PhotoPharmics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.